Sanofi
SNY
$48.61
Share price
-1.48%
Change (1 day)
-5.08%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
Sanofi (SNY) Fails to deliver data
Key failure to deliver metrics for Sanofi:
- Last SEC data release: 2025-06-13
- Last 15 days FTD volume: $0.52 M
- Last 3 months FTD volume: $28.45 M
- Last year FTD volume: $28.45 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Sanofi (SNY) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Sanofi (SNY) - since 2013
Volume in USD (price x number of shares), data since 2013Sanofi (SNY) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | $28.91 M | -60.29% |
| 2024 | $72.79 M | 38.11% |
| 2023 | $52.7 M | -56.32% |
| 2022 | $0.12 B | 1.16% |
| 2021 | $0.11 B | -32.73% |
| 2020 | $0.17 B | 32.11% |
| 2019 | $0.13 B | 26.98% |
| 2018 | $0.10 B | 19.58% |
| 2017 | $88.39 M | -57.53% |
| 2016 | $0.20 B | 339.69% |
| 2015 | $47.34 M | -81.06% |
| 2014 | $0.24 B | 611.53% |
| 2013 | $35.12 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Merck MRK | $19.75 M | $0.17 B | 🇺🇸 USA |
 Pfizer PFE | $27.54 M | $0.27 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $12.67 M | $0.27 B | 🇺🇸 USA |
 Novartis NVS | $30.86 M | $0.15 B | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | $64.68 M | $0.32 B | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $12.54 M | $40.84 M | 🇮🇱 Israel |
 Johnson & Johnson JNJ | $10.35 M | $0.19 B | 🇺🇸 USA |
 Eli Lilly LLY | $34.52 M | $0.21 B | 🇺🇸 USA |
 Novo Nordisk NVO | $55.95 M | $0.27 B | 🇩🇰 Denmark |
 Abbott Laboratories ABT | $33.15 M | $0.37 B | 🇺🇸 USA |